Issue Code: PHA
1,458
434
265
2025--2026
LMH STRATEGIC SOLUTIONS
45 activities
B HALL STRATEGIES, LLC
39 activities
MEHLMAN CONSULTING, INC.
37 activities
MARSHALL & POPP, LLC
HOUSE OF REPRESENTATIVES
1,153 mentionsSENATE
1,144 mentionsHealth & Human Services, Dept of (HHS)
293 mentionsCenters For Medicare and Medicaid Services (CMS)
CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER
via CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER
340b, white bagging
PUBLIC CITIZEN
via PUBLIC CITIZEN
Medicare drug price negotiation improvement and expansion; EPIC Act (H.R. 1492 / S. 832), MINI Act (H.R.1672); Medicare drug price negotiation delay periods and exemptions; drug prices; NDAA & public drug and API manufacturing,S.2276, H.R.3269 (ETHIC Act).
36 activities
TODD STRATEGY GROUP
33 activities
RUBICON ADVISORS, LLC
30 activities
DLA PIPER LLP (US)
27 activities
BALLARD PARTNERS
27 activities
KOUNTOUPES DENHAM CARR & REID, LLC
25 activities
BGR GOVERNMENT AFFAIRS
25 activities
Food & Drug Administration (FDA)
138 mentionsWhite House Office
121 mentionsExecutive Office of the President (EOP)
80 mentionsHealth Resources & Services Administration (HRSA)
30 mentionsOffice of Management & Budget (OMB)
28 mentionsCommerce, Dept of (DOC)
25 mentionsAMERICAN VETERINARY MEDICAL ASSOCIATION
via AMERICAN VETERINARY MEDICAL ASSOCIATION
Xylazine; Combating Illicit Xylazine Act (HR1266/S545); Controlled Substances used in veterinary medicine, Controlled Substances Act and regulations as related to veterinary medicine. Issues related to the FDA CVM.
GS1 US
via KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to the pharmaceutical supply chain.
CONSUMER HEALTHCARE PRODUCTS ASSOCIATION
via KOUNTOUPES DENHAM CARR & REID, LLC
General issues related to over-the-counter (OTC) pharmaceutical supply chain.
CENCORA INC. (FORMERLY AMERISOURCEBERGEN CORPORATION)
via KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to the pharmaceutical supply chain, drug shortages, and national stockpiles.
AMERICAN KRATOM ASSOCIATION
via KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to Food and Drug Administration regulatory and consumer access. Issues related to the Federal Kratom Consumer Protection Act. Issues related to the Controlled Substances Act (Public Law 91-513).
TIBER CREEK HEALTH STRATEGIES, INC. ON BEHALF OF AMGEN, INC.
via B HALL STRATEGIES, LLC
Issues related to drug pricing.
TIBER CREEK HEALTH STRATEGIES, INC. ON BEHALF OF NOVARTIS
via B HALL STRATEGIES, LLC
Issues related to drug pricing. Issues related to PBM reform.
TIBER CREEK HEALTH STRATEGIES, INC. ON BEHALF OF GENENTECH, INC.
via B HALL STRATEGIES, LLC
Issues related to drug pricing.